Abstract
Background The novel coronavirus responsible for COVID-19 has caused havoc with patients presenting a spectrum of complications forcing the healthcare experts around the globe to explore new technological solutions, and treatment plans. Machine learning (ML) based technologies have played a substantial role in solving complex problems, and several organizations have been swift to adopt and customize them in response to the challenges posed by the COVID-19 pandemic.
Objective The objective of this study is to conduct a systematic literature review on the role of ML as a comprehensive and decisive technology to fight the COVID-19 crisis in the arena of epidemiology, diagnosis, and disease progression.
Methods A systematic search in PubMed, Web of Science, and CINAHL databases was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines to identify all potentially relevant studies published and made available between December 1, 2019, and June 27, 2020. The search syntax was built using keywords specific to COVID-19 and ML. A total of 128 qualified articles were reviewed and analyzed based on the study objectives.
Results The 128 publications selected were classified into three themes based on ML applications employed to combat the COVID-19 crisis: Computational Epidemiology (CE), Early Detection and Diagnosis (EDD), and Disease Progression (DP). Of the 128 studies, 70 focused on predicting the outbreak, the impact of containment policies, and potential drug discoveries, which were grouped into the CE theme. For the EDD, we grouped forty studies that applied ML techniques to detect the presence of COVID-19 using the patients’ radiological images or lab results. Eighteen publications that focused on predicting the disease progression, outcomes (recovery and mortality), Length of Stay (LOS), and number of Intensive Care Unit (ICU) days for COVID-19 positive patients were classified under the DP theme.
Conclusions In this systematic review, we assembled the current COVID-19 literature that utilized ML methods to provide insights into the COVID-19 themes, highlighting the important variables, data types, and available COVID-19 resources that can assist in facilitating clinical and translational research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not Applicable.Review of available evidence
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data sharing/availability is not applicable to this article as it is a review article.
Abbreviations
- AI
- Artificial Intelligence
- AIDS
- Acquired Immunodeficiency Syndrome
- ALT
- alanine aminotransferase
- ANN
- Artificial Neural Network
- ARDS
- Acute Respiratory Distress Syndrome
- ARIMA
- Auto-Regressive Integrated Moving Average
- AUC
- Area Under the Curve
- AUROC
- Area Under the Receiver Operating Characteristics
- CBC
- Complete Blood Count
- CDT
- COVID-19 Disease Trajectory
- CE
- Computational Epidemiology
- CNN
- Convolutional Neural Network
- CRP
- C – reactive protein
- CT
- Computed Tomography
- CXR
- Chest X-Ray
- DD
- Deep Docking
- DL
- Deep Learning
- DP
- Disease Progression
- EDD
- Early Detection and Diagnosis
- EGFR
- Epidermal Growth Factor Receptor
- FCR
- Facilitate COVID-19 Response
- HBM
- Health Belief Model
- EHR
- Electronic Health Record
- ICU
- Intensive Care Unit
- IL-6
- Interleukin-6
- LOS
- Length of Stay
- LSTM
- Long-Short Term Memory
- LUS
- Lung Ultrasound
- MADD
- Molecular Analysis-Drug Discovery
- ML
- Machine Learning
- Mpro
- Main Protease
- MT-DTI
- Molecule Transformer-Drug Target Interaction
- N3C
- National COVID Cohort Collaborative
- NCATS
- National Center for Advancing Translational Sciences
- NCBI
- National Center for Biotechnology Information
- NLP
- Natural Language Processing
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-analysis
- RT-PCR
- Reverse Transcription Polymerase Chain Reaction
- SARS
- Severe Acute Respiratory Syndrome
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- SEIR
- Specifically, Susceptible-Exposed-Infectious-Recovered
- SOFA
- Sequential Organ Failure Assessment
- SVM
- Support Vector Machine
- XGBoost
- Extreme Gradient Boosting
- X-Ray
- X-Radiation
